If you're apprehensive about getting an intravitreal injection for age-related macular degeneration (AMD), you're not alone. Ophthalmologist Monika Fleckenstein, MD, explains the procedure, how it can ...

Please provide your email address to receive an email when new articles are posted on . The phase 1/2 PRISM trial evaluated the safety, efficacy and durability of 4D-150. Participants experienced ...

An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...

Please provide your email address to receive an email when new articles are posted on . The most common ophthalmic procedure is an intravitreal injection, with more than 10 million per year performed ...

At the American Academy of Ophthalmology (AAO) annual meeting, new data were presented from a 7-month analysis on OTX-TKI, an axitinib (Inlyta) intravitreal implant being evaluated for the treatment ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...

The FDA has granted Orphan Drug designation to ADX-2191 (methotrexate for intravitreal injection) for the treatment of retinitis pigmentosa. The Food and Drug Administration (FDA) has granted Orphan ...

According to the report, the study examined 24 patients who were intravitreally injected four times in combination with four different types of anesthesia: topical proparacaine, topical tetracaine, ...